170 related articles for article (PubMed ID: 30151375)
1. Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients.
Lubowicka E; Przylipiak A; Zajkowska M; Piskór BM; Malinowski P; Fiedorowicz W; Ławicki S
Biomed Res Int; 2018; 2018():2124390. PubMed ID: 30151375
[TBL] [Abstract][Full Text] [Related]
2. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
[TBL] [Abstract][Full Text] [Related]
3. C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients.
Dąbrowska E; Przylipiak A; Zajkowska M; Piskór BM; Borowik-Zaręba A; Ławicki S
Acta Biochim Pol; 2020 Nov; 67(4):539-449. PubMed ID: 33245226
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer.
Zajkowska M; Lubowicka E; Malinowski P; Szmitkowski M; Ławicki S
Acta Biochim Pol; 2018 Dec; 65(4):621-628. PubMed ID: 30543720
[TBL] [Abstract][Full Text] [Related]
5. Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
Zajkowska M; Gacuta E; Lubowicka E; Szmitkowski M; Ławicki S
Acta Biochim Pol; 2020 Mar; 67(1):25-29. PubMed ID: 32160452
[TBL] [Abstract][Full Text] [Related]
6. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
Ławicki S; Głażewska EK; Sobolewska M; Będkowska GE; Szmitkowski M
Ann Lab Med; 2016 May; 36(3):223-9. PubMed ID: 26915610
[TBL] [Abstract][Full Text] [Related]
7. Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
Zajkowska M; Lubowicka E; Fiedorowicz W; Szmitkowski M; Jamiołkowski J; Ławicki S
Pathol Oncol Res; 2019 Oct; 25(4):1477-1486. PubMed ID: 30387014
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.
Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
Biomarkers; 2017 Mar; 22(2):157-164. PubMed ID: 27775427
[TBL] [Abstract][Full Text] [Related]
9. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
10. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
Ławicki S; Będkowska GE; Szmitkowski M
Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065
[TBL] [Abstract][Full Text] [Related]
11. Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer.
Piskór BM; Przylipiak A; Dąbrowska E; Sidorkiewicz I; Niczyporuk M; Szmitkowski M; Ławicki S
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33916127
[TBL] [Abstract][Full Text] [Related]
12. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
[TBL] [Abstract][Full Text] [Related]
13. CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis.
Diaz-Rubio GI; Corona-Meraz FI; Madrigal-Ruiz PM; Robles-De Anda JA; Gómez-Bañuelos E; Castro-Albarran J; Flores-Alvarado LJ; Vázquez-Del Mercado M; Pérez-Vázquez FJ; Pizano-Martínez OE; Navarro-Hernández RE
PLoS One; 2021; 16(1):e0246054. PubMed ID: 33508012
[TBL] [Abstract][Full Text] [Related]
14. Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer.
Piskór BM; Przylipiak A; Dąbrowska E; Sidorkiewicz I; Niczyporuk M; Szmitkowski M; Ławicki S
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33371324
[TBL] [Abstract][Full Text] [Related]
15. CCL2 Serum Levels and Adiposity Are Associated with the Polymorphic Phenotypes -2518A on CCL2 and 64ILE on CCR2 in a Mexican Population with Insulin Resistance.
Guzmán-Ornelas MO; Petri MH; Vázquez-Del Mercado M; Chavarría-Ávila E; Corona-Meraz FI; Ruíz-Quezada SL; Madrigal-Ruíz PM; Castro-Albarrán J; Sandoval-García F; Navarro-Hernández RE
J Diabetes Res; 2016; 2016():5675739. PubMed ID: 26839895
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.
Zajkowska M; Głażewska EK; Będkowska GE; Chorąży P; Szmitkowski M; Ławicki S
Mediators Inflamm; 2016; 2016():5962946. PubMed ID: 27445439
[TBL] [Abstract][Full Text] [Related]
17. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
18. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.
Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
Onco Targets Ther; 2016; 9():911-9. PubMed ID: 26966379
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.
Zajkowska M; Gacuta E; Kozłowska S; Lubowicka E; Głażewska EK; Chrostek L; Szmitkowski M; Pawłowski P; Zbucka-Krętowska M; Ławicki S
Adv Med Sci; 2019 Mar; 64(1):1-8. PubMed ID: 30227310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
